Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Details for Australian Patent Application No. 2002342463 (hide)

Owner Nymox Corporation

Inventors Averback, Paul; Gemmell, Jack

Agent FB Rice

Pub. Number AU-B-2002342463

PCT Number PCT/CA02/01757

PCT Pub. Number WO2003/044053

Priority 60/331,477 16.11.01 US

Filing date 18 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 4 September 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/331,477 16.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002342463

4 September 2008 Application Accepted

  Published as AU-B-2002342463

28 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342464-XYLANASES WITH ENHANCED THERMOPHILICITY AND ALKALOPHILICITY

2002342462-COMPOSITION AND METHOD TO HOMOGENEOUSLY MODIFY OR CROSS-LINK CHITOSAN UNDER NEUTRAL CONDITIONS